Cargando…

Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication

Domperidone is an antagonist of the peripheral dopamine (D2) receptor. It works as an antiemetic by blocking D2-receptors at the chemoreceptor trigger zone and as a gastroprokinetic drug by blocking GI tract D2-receptors. According to research, using domperidone significantly raises the risk of card...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalwar, Asifa, Mangi, Rabel Q., Rehman, Junaid U., Ochani, Sidhant, Faraz, Muhammad, Kukreja, Sandhaya, Hasibuzzaman, Md. Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289668/
https://www.ncbi.nlm.nih.gov/pubmed/37363600
http://dx.doi.org/10.1097/MS9.0000000000000723
_version_ 1785062328924897280
author Kalwar, Asifa
Mangi, Rabel Q.
Rehman, Junaid U.
Ochani, Sidhant
Faraz, Muhammad
Kukreja, Sandhaya
Hasibuzzaman, Md. Al
author_facet Kalwar, Asifa
Mangi, Rabel Q.
Rehman, Junaid U.
Ochani, Sidhant
Faraz, Muhammad
Kukreja, Sandhaya
Hasibuzzaman, Md. Al
author_sort Kalwar, Asifa
collection PubMed
description Domperidone is an antagonist of the peripheral dopamine (D2) receptor. It works as an antiemetic by blocking D2-receptors at the chemoreceptor trigger zone and as a gastroprokinetic drug by blocking GI tract D2-receptors. According to research, using domperidone significantly raises the risk of cardiac arrhythmia and sudden cardiac death by 70%, most likely through prolonging the QT interval. Blockade of hERG voltage-gated potassium channels is thought to be the reason. Here in Pakistan, this drug is being prescribed by every other physician and even patients frequently self-medicate themselves with it. Due to the serious side effects of this medication, extreme caution should be exercised when prescribing it, especially to the elderly, those who have underlying QT prolongation, those taking medications known to prolong QT, and even more so in pregnant women as there is some evidence that domperidone crosses into breast milk in small amounts and causes an irregular heartbeat in the baby. At least we, on our part, can limit the usage of the drug only with a prescription and, where necessary, if not completely, stop it.
format Online
Article
Text
id pubmed-10289668
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102896682023-06-24 Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication Kalwar, Asifa Mangi, Rabel Q. Rehman, Junaid U. Ochani, Sidhant Faraz, Muhammad Kukreja, Sandhaya Hasibuzzaman, Md. Al Ann Med Surg (Lond) Short Communications Domperidone is an antagonist of the peripheral dopamine (D2) receptor. It works as an antiemetic by blocking D2-receptors at the chemoreceptor trigger zone and as a gastroprokinetic drug by blocking GI tract D2-receptors. According to research, using domperidone significantly raises the risk of cardiac arrhythmia and sudden cardiac death by 70%, most likely through prolonging the QT interval. Blockade of hERG voltage-gated potassium channels is thought to be the reason. Here in Pakistan, this drug is being prescribed by every other physician and even patients frequently self-medicate themselves with it. Due to the serious side effects of this medication, extreme caution should be exercised when prescribing it, especially to the elderly, those who have underlying QT prolongation, those taking medications known to prolong QT, and even more so in pregnant women as there is some evidence that domperidone crosses into breast milk in small amounts and causes an irregular heartbeat in the baby. At least we, on our part, can limit the usage of the drug only with a prescription and, where necessary, if not completely, stop it. Lippincott Williams & Wilkins 2023-04-27 /pmc/articles/PMC10289668/ /pubmed/37363600 http://dx.doi.org/10.1097/MS9.0000000000000723 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Short Communications
Kalwar, Asifa
Mangi, Rabel Q.
Rehman, Junaid U.
Ochani, Sidhant
Faraz, Muhammad
Kukreja, Sandhaya
Hasibuzzaman, Md. Al
Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication
title Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication
title_full Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication
title_fullStr Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication
title_full_unstemmed Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication
title_short Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication
title_sort lack of knowledge regarding the misuse of domperidone in pakistan and its serious consequences: short communication
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289668/
https://www.ncbi.nlm.nih.gov/pubmed/37363600
http://dx.doi.org/10.1097/MS9.0000000000000723
work_keys_str_mv AT kalwarasifa lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication
AT mangirabelq lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication
AT rehmanjunaidu lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication
AT ochanisidhant lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication
AT farazmuhammad lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication
AT kukrejasandhaya lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication
AT hasibuzzamanmdal lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication